- Home
- SB vs PRTA Comparison
SB vs PRTA Comparison
Compare SB & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SB | PRTA |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Monaco | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.9M | 495.8M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SB | PRTA |
|---|---|---|
| Price | $5.13 | $9.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $6.00 | ★ $18.86 |
| AVG Volume (30 Days) | 501.0K | ★ 683.2K |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | ★ 3.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $274,661,000.00 | $11,786,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.74 | $1,183.79 |
| P/E Ratio | $13.99 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $4.32 |
| 52 Week High | $5.54 | $16.67 |
Technical Indicators
Market Signals| Indicator | SB | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 48.04 |
| Support Level | $5.09 | $8.65 |
| Resistance Level | $5.31 | $9.34 |
| Average True Range (ATR) | 0.12 | 0.36 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 66.98 | 69.71 |
Price Performance
Historical ComparisonAbout SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.